Natalizumab monoclonal antibody drug. Targets integrin a4 and is indicated for use in the treatment of multiple sclerosis and Crohn's disease. Generic

---

Natalizumab monoclonal antibody drug. Targets integrin a4 and is indicated for use in the treatment of multiple sclerosis and Crohn's disease. Generic name and stylized antibody.

---

Size: 9000px × 4647px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: a4, adhesion, alpha, antibody, antigen, biological, biosimilar, biotech, biotechnology, cell, crohn, disease, drug, humanized, immunoglobulin, immunology, infusion, injection, inn, integrin, jc, late, leukoencephalophathy, mab, molecule, monoclonal, ms, multifocal, multiple, natalizumab, nomenclature, peptide, pml, progressive, protein, sclerosis, virus, vla-4